To improve security and privacy, we are moving our web pages and services from HTTP to HTTPS.
To give users of web services time to transition to HTTPS, we will support separate HTTP and HTTPS services until the end of 2017.
From January 2018 most HTTP traffic will be automatically redirected to HTTPS. [more...]
View this page in https

ENZYME entry: EC 1.14.13.181

Accepted Name
13-deoxydaunorubicin hydroxylase.
Reaction catalysed
  • 13-deoxydaunorubicin + NADPH + O(2) <=> 13-dihydrodaunorubicin + NADP(+) + H(2)O
  • 13-dihydrodaunorubicin + NADPH + O(2) <=> daunorubicin + NADP(+) + 2 H(2)O
Comment(s)
The enzymes from the Gram-positive bacteria Streptomyces sp. C5 and Streptomyces peucetius show broad substrate specificity for structures based on an anthracycline aglycone, but have a strong preference for 4-methoxy anthracycline intermediates (13-deoxydaunorubicin and 13-dihydrodaunorubicin) over their 4-hydroxy analogs (13-deoxycarminomycin and 13-dihydrocarminomycin), as well as a preference for substrates hydroxylated at the C-13 rather than the C-14 position.
Cross-references
BRENDA1.14.13.181
EC2PDB1.14.13.181
ExplorEnz1.14.13.181
PRIAM enzyme-specific profiles1.14.13.181
KEGG Ligand Database for Enzyme Nomenclature1.14.13.181
IUBMB Enzyme Nomenclature1.14.13.181
IntEnz1.14.13.181
MEDLINEFind literature relating to 1.14.13.181
MetaCyc1.14.13.181
UniProtKB/Swiss-Prot
Q93MI2, DOXA_STRC0;  Q9ZAU3, DOXA_STRPE;  Q59971, DOXA_STRS5;  

View entry in original ENZYME format
View entry in raw text format (no links)

All UniProtKB/Swiss-Prot entries referenced in this entry, with possibility to download in different formats, align etc.
All ENZYME / UniProtKB/Swiss-Prot entries corresponding to 1.14.13.-
All ENZYME / UniProtKB/Swiss-Prot entries corresponding to 1.14.-.-
All ENZYME / UniProtKB/Swiss-Prot entries corresponding to 1.-.-.-